A23V 2250/1608
Molybdenum
A23V2250/1608 (Molybdenum) appears on 3 US grants and 4 published applications in this corpus.
Search patents in A23V- Granted patents
- 3
- Published applications
- 4
- Assignees
- 4
- Inventors
- 13
- Latest grant
- 4 Jan 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 2 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
By publication year.
Recent patents
- Nutritional formulations and kits for bariatric individuals4 Jan 2022US 11,213,059 B2Mantra Pharma
- Functionalized transition metal dichalcogenides and composition for antioxidation containing the same30 Jun 2020US 10,695,282 B2Amorepacific Corporation
- Nutritional formulations using human milk oligosaccharides for modulating inflammation21 Apr 2020US 10,624,916 B2Abbott Laboratories
- Nutritional formulations using human milk oligosaccharides for modulating inflammation23 Jul 2020US 2020/0230162 A1Abbott Laboratories
- Functionalized transition metal dichalcogenides and composition for antioxidation containing the same18 Jul 2019US 2019/0216715 A1Amorepacific Corporation
- Nutritional formulations and kits for bariatric individuals27 Jun 2019US 2019/0191754 A1Mantra Pharma
- Nutritional formulations using human milk oligosaccharides for modulating inflammation8 Sep 2016US 2016/0256479 A1Abbott Laboratories
Most cited
By later US patents